Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
25/09/201908h01RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Presents SANET-ep Phase III data at ESMOLSE:0J7GHutchison China Meditech Ltd
18/09/201908h01RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Highlights Presentations at 2019 CSCOLSE:0J7GHutchison China Meditech Ltd
03/09/201908h19RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med to present at MS conferenceLSE:0J7GHutchison China Meditech Ltd
03/09/201908h01UK RegulatoryHutchison China Meditech Limited Chi-Med initiates Phase I trialLSE:0J7GHutchison China Meditech Ltd
30/08/201908h01UK RegulatoryHutchison China Meditech Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
23/08/201908h00UK RegulatoryHutchison China Meditech Limited Start of Clinical Trial in ChinaLSE:0J7GHutchison China Meditech Ltd
20/08/201908h48UK RegulatoryHutchison China Meditech Limited Holding(s) in CompanyLSE:0J7GHutchison China Meditech Ltd
30/07/201911h48UK RegulatoryHutchison China Meditech Limited TR-1: Form for notification of major holdingsLSE:0J7GHutchison China Meditech Ltd
30/07/201908h02UK RegulatoryHutchison China Meditech Limited 2019 Interim Results and Clinical Programs UpdateLSE:0J7GHutchison China Meditech Ltd
10/07/201917h35UK RegulatoryHutchison China Meditech Limited Price Monitoring ExtensionLSE:0J7GHutchison China Meditech Ltd
03/07/201908h00UK RegulatoryHutchison China Meditech Limited Chi-Med to Announce 2019 Half-Year ResultsLSE:0J7GHutchison China Meditech Ltd
28/06/201912h10UK RegulatoryHutchison China Meditech Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
28/06/201911h07UK RegulatoryHutchison China Meditech Limited Pricing of U.S. Public Secondary Offering of ADSsLSE:0J7GHutchison China Meditech Ltd
28/06/201908h01UK RegulatoryHutchison China Meditech Limited Secondary Offering of American Depositary SharesLSE:0J7GHutchison China Meditech Ltd
21/06/201917h40UK RegulatoryHutchison China Meditech Limited Second Price Monitoring ExtnLSE:0J7GHutchison China Meditech Ltd
14/06/201910h00UK RegulatoryHutchison China Meditech Limited Surufatinib Phase III Study Meets Primary EndpointLSE:0J7GHutchison China Meditech Ltd
12/06/201910h18UK RegulatoryHutchison China Meditech Limited Block Admission Applications & Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
06/06/201908h01UK RegulatoryHutchison China Meditech Limited Disclosure UpdateLSE:0J7GHutchison China Meditech Ltd
29/05/201913h06UK RegulatoryHutchison China Meditech Limited Results of Extraordinary General MeetingLSE:0J7GHutchison China Meditech Ltd
22/05/201912h03UK RegulatoryHutchison China Meditech Limited Grant of Share Options under Share Option SchemeLSE:0J7GHutchison China Meditech Ltd
29/03/201908h02RNS Non-RegulatoryHutchison China Meditech Limited Start of Phase IIb/III Surufatinib Trial in ChinaLSE:0J7GHutchison China Meditech Ltd
28/03/201908h30RNS Non-RegulatoryHutchison China Meditech Limited Savolitinib Lung Cancer Presentations at AACRLSE:0J7GHutchison China Meditech Ltd
11/03/201913h54RNS Non-RegulatoryHutchison China Meditech Limited Publication of Form 20-FLSE:0J7GHutchison China Meditech Ltd
12/02/201908h00RNS Non-RegulatoryHutchison China Meditech Limited Savolitinib PRCC Data to be presented at ASCO GULSE:0J7GHutchison China Meditech Ltd
07/01/201908h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Presents at JPM Healthcare ConferenceLSE:0J7GHutchison China Meditech Ltd
29/11/201809h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Enters into Multiple CollaborationsLSE:0J7GHutchison China Meditech Ltd
26/11/201808h01RNS Non-RegulatoryHutchison China Meditech Limited First Commercial Launch of Fruquintinib CapsulesLSE:0J7GHutchison China Meditech Ltd
18/10/201808h01RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Initiates a Ph I Trial of HMPL-523 for AMLLSE:0J7GHutchison China Meditech Ltd
27/07/201808h00UK RegulatoryHutchison China Meditech Limited 2018 Interim Results and Clinical Programs UpdateLSE:0J7GHutchison China Meditech Ltd
23/07/201808h00RNS Non-RegulatoryHutchison China Meditech Limited Start of Sulfatinib US Phase Ib/II PoC trialLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G